Market Cap 282.68M
Revenue (ttm) 56.13M
Net Income (ttm) -14.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 31.33
Profit Margin -26.14%
Debt to Equity Ratio 0.97
Volume 128,900
Avg Vol 128,662
Day's Range N/A - N/A
Shares Out 33.26M
Stochastic %K 76%
Beta 0.81
Analysts Strong Sell
Price Target $13.50

Company Profile

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 480 434 6670
Address:
9237 East Via de Ventura Boulevard, Suite 105, Scottsdale, United States
TriggerCrafter
TriggerCrafter Feb. 18 at 10:33 AM
$DERM Dermatology-focused biotech with commercialization hurdles.
1 · Reply
FadeMonitor
FadeMonitor Feb. 18 at 7:12 AM
$DERM DermTech provides non-invasive skin cancer genomics tests, facing slow commercial adoption and reimbursement challenges [citation:historical].
1 · Reply
Tomasini
Tomasini Feb. 17 at 7:13 PM
$DERM finally some movement
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 17 at 4:40 AM
$DERM RSI: 29.70, MACD: -0.0397 Vol: 0.38, MA20: 8.39, MA50: 8.01 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Tomasini
Tomasini Feb. 12 at 5:47 PM
$DERM has there been an er date announced?
1 · Reply
Tomasini
Tomasini Feb. 12 at 3:46 PM
$DERM getting some good opportunities to buy before er. whole biomarket is under short attack
0 · Reply
Tomasini
Tomasini Feb. 9 at 5:50 PM
$DERM great buying opp here at 7.65
0 · Reply
FinSUN
FinSUN Feb. 9 at 5:18 PM
$DERM and here you go.
0 · Reply
flyinghollaender
flyinghollaender Feb. 9 at 4:54 PM
$DERM last drip before >10$
0 · Reply
buymoremakemore
buymoremakemore Feb. 9 at 4:15 PM
$DERM Lol fbio up and derm down. Come get your derm cheapies!!
1 · Reply
Latest News on DERM
Top 3 Health Care Stocks That May Crash In Q2

Apr 7, 2025, 11:23 AM EDT - 11 months ago

Top 3 Health Care Stocks That May Crash In Q2

ALMS CMRX


TriggerCrafter
TriggerCrafter Feb. 18 at 10:33 AM
$DERM Dermatology-focused biotech with commercialization hurdles.
1 · Reply
FadeMonitor
FadeMonitor Feb. 18 at 7:12 AM
$DERM DermTech provides non-invasive skin cancer genomics tests, facing slow commercial adoption and reimbursement challenges [citation:historical].
1 · Reply
Tomasini
Tomasini Feb. 17 at 7:13 PM
$DERM finally some movement
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 17 at 4:40 AM
$DERM RSI: 29.70, MACD: -0.0397 Vol: 0.38, MA20: 8.39, MA50: 8.01 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Tomasini
Tomasini Feb. 12 at 5:47 PM
$DERM has there been an er date announced?
1 · Reply
Tomasini
Tomasini Feb. 12 at 3:46 PM
$DERM getting some good opportunities to buy before er. whole biomarket is under short attack
0 · Reply
Tomasini
Tomasini Feb. 9 at 5:50 PM
$DERM great buying opp here at 7.65
0 · Reply
FinSUN
FinSUN Feb. 9 at 5:18 PM
$DERM and here you go.
0 · Reply
flyinghollaender
flyinghollaender Feb. 9 at 4:54 PM
$DERM last drip before >10$
0 · Reply
buymoremakemore
buymoremakemore Feb. 9 at 4:15 PM
$DERM Lol fbio up and derm down. Come get your derm cheapies!!
1 · Reply
Tomasini
Tomasini Feb. 6 at 8:04 PM
$DERM market nuts and this dopg walks like a yoyo
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 4 at 4:50 PM
$DERM Current Stock Price: $8.44 Contracts to trade: $7.5 DERM Feb 20 2026 Call Entry: $0.74 Exit: $0.94 ROI: 27% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
T_rader
T_rader Jan. 29 at 12:12 PM
$DERM approaching a buy zone for the ole rinse and repeat
0 · Reply
FinSUN
FinSUN Jan. 29 at 10:04 AM
$DERM I knew there was something behind this inconclusive and hearratic price movements Journey Medical Files 3.75M shares At-The-Market Common Stock Offering With B. Riley And Lake Street and it's number of shares, not $ amount as some press release would make you think. Not too much compared to the float, but an ATM with nothing else than B Fucking Riley !! This management is still in bed with them, I knew it. Even by principle I cannot touch anything that has this type of deals going on. I don't care if they are gonna pump it. SELL for me and case closed.
2 · Reply
flyinghollaender
flyinghollaender Jan. 28 at 5:05 PM
$DERM loaded 6k shares now. 2026 will be the best $DERM year ever!
0 · Reply
buymoremakemore
buymoremakemore Jan. 26 at 11:48 PM
$DERM Yes generic doxy is cheap, but it causes people acne and stomach problems. Part of the reason why emrosi has been getting prescribed like crazy not just for rosacea but off label for acne too. Dermatologists may to some extent throwing at the wall and seeing what sticks, but that benefits Emrosi when a lot will stick and people will keep regularly taking it.
0 · Reply
JFais
JFais Jan. 23 at 4:33 PM
$DERM- liking this chart pattern ahead of Q4/FY 25 report (historically last week of March)
1 · Reply
hofno2003
hofno2003 Jan. 23 at 8:24 AM
$DERM Very near to break-even in regard to cash-flow and net-earnings. Maybe already in the to report 4th quarter, at the latest in 1st quarter of 2026.
0 · Reply
omega42
omega42 Jan. 23 at 2:28 AM
$DERM $FBIO at the present time DERM's MC is at 5x of the current revenue of appx $60M. applying that to future peak revenues of $300M for Emrosi only, that's MC or appx $1.5B or $45 per share based on current share count. Something to ponder on
3 · Reply
omega42
omega42 Jan. 23 at 2:00 AM
$DERM getting a feeling we may hit $11 preearning release in early mid march. lot further along on Emrosi comercialization with scripts being up significantly and EBITDA break even on horizon which will make this one move vioulently if achieved.
0 · Reply